Literature DB >> 4290376

Suppression of tumorous adrenal hyperfunction by aminoglutethimide.

R P Smilo, J M Earll, P H Forsham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4290376     DOI： 10.1016/0026-0495(67)90048-0

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Changes in the fine structure and function of a hormone-secreting adrenocortical tumour investigated in tissue culture.

Authors:  D Szabó; A Gyévai; E Gláz; E Stark; M Péteri; O Alánt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-09-18

2.  The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide.

Authors:  C B Vaughn; S Pearson; J Chapman; B Chinn; D Banks
Journal:  J Natl Med Assoc       Date:  1979-01       Impact factor: 1.798

3.  Effects of aminoglutethimide (Elipten Ciba), a steroid biosynthesis blocking agent, on adrenal glands in Cushing's syndrome.

Authors:  K Motlík; P Pinsker; L Stárka; E Hradec
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973

Review 4.  Aminoglutethimide: a "side-effect" turned to therapeutic advantage.

Authors:  S W Hughss; D M Burley
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

5.  Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.

Authors:  I G Barnett; J D Nabarro; L P LeQuesne
Journal:  Proc R Soc Med       Date:  1970-04

6.  Management of acute hypercortisolism.

Authors:  N W Thompson; M D Allo
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

Review 7.  Feminizing adrenocortical tumors: Literature review.

Authors:  Farida Chentli; Ilyes Bekkaye; Said Azzoug
Journal:  Indian J Endocrinol Metab       Date:  2015 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.